It is therefore possible that the apparent lack of a beneficial effect for those targeted to higher hemoglobins in all previous RCTs as well as in observational studies could be due to the mixing of diabetic and nondiabetic patients in their study groups.Whether the adverse effects of targeting normal hemoglobins is due to the hemoglobin level or other factors remains controversial.